| Identification | Back Directory | [Name]
LNK754 | [CAS]
439153-64-7 | [Synonyms]
(Rac)-CP-609754
(Rac) CP 609754,(Rac)CP609754
2(1H)-Quinolinone, 6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-ethynylphenyl)-1-methyl- | [Molecular Formula]
C33H28ClN3O8 | [MDL Number]
MFCD25976835 | [MOL File]
439153-64-7.mol | [Molecular Weight]
630.044 |
| Chemical Properties | Back Directory | [Boiling point ]
702.4±60.0 °C(Predicted) | [density ]
1.23±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [pka]
12.28±0.29(Predicted) |
| Hazard Information | Back Directory | [Uses]
(Rac)-CP-609754 is the racemate of CP-609754. CP-609754 is a farnesyltransferase inhibitor, used for the treatment of cancer and Alzheimer's disease. | [References]
[1] Keith T Gagnon. HD Therapeutics-CHDI Fifth Annual Conference. IDrugs. 2010 Apr;13(4):219-23. PMID:20373247 |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310; |
| Website: |
https://www.weikeqi-biotech.com/ |
|